tiprankstipranks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market

Vertex Pharmaceuticals (VRTX) Income Statement

Compare
5,958 Followers

Vertex Pharmaceuticals Income Statement

Last quarter (Q4 2024), Vertex Pharmaceuticals's total revenue was $2.91B, an increase of 15.66% from the same quarter last year. In Q4, Vertex Pharmaceuticals's net income was $913.00M. See Vertex Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 11.02B$ 9.87B$ 8.93B$ 7.57B$ 6.21B
Gross Profit
$ 9.49B$ 8.61B$ 7.85B$ 6.67B$ 5.47B
Operating Expenses
$ 9.72B$ 4.78B$ 3.48B$ 3.89B$ 2.60B
Depreciation and Amortization
$ 207.20M$ 181.30M$ 148.30M$ 125.60M$ 109.52M
EBITDA
$ 486.30M$ 4.61B$ 4.44B$ 2.92B$ 3.28B
Operating Income
$ -232.90M$ 4.31B$ 4.31B$ 2.78B$ 2.86B
Other Income/Expenses
$ 481.40M$ 72.30M$ -75.00M$ -51.70M$ 62.80M
Pretax Income
$ 248.50M$ 4.38B$ 4.23B$ 2.73B$ 3.12B
Net Income
$ -535.60M$ 3.62B$ 3.32B$ 2.34B$ 2.71B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.08$ 14.05$ 12.97$ 9.09$ 10.44
Diluted EPS
$ -2.08$ 13.89$ 12.82$ 9.01$ 10.29
Weighted Average Shares Outstanding
257.50M 257.70M 256.10M 257.70M 259.84M
Weighted Average Shares Outstanding (Diluted)
257.90M 260.50M 259.10M 259.90M 263.40M
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis